Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI)

NCT00093184 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00093184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00093184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2005
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction